SAGENT
Live / Allowed — Notice of allowance issued (as of 29 Apr 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98637116
- Mark type
- Design + words
- Filed
- 08 Jul 2024
- Published for opposition
- 04 Mar 2025
- Attorney of record
- Tamara A. Miller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, anesthetics, anti-infectives, antiemetics, antipsychotics, blood modifiers, cardiovasculars, and oncolytics; pre-filled syringes sold filled with cardiovasculars; pharmaceuticals for treatment of cancer; injectable drugs and therapeutic solutions for the treatment of cancer, cardiovascular disease, infections, pain, and psychotic disorders; injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors
Owner
- SAGENT PHARMACEUTICALS, SCHAUMBURG, IL, US
- SAGENT PHARMACEUTICALS, SCHAUMBURG, IL, US
Prior registrations
Prosecution history
- 01 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Mar 2026 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 10 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Oct 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 23 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 23 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Mar 2025 — PUBLISHED FOR OPPOSITION
- 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Jan 2025 — ASSIGNED TO EXAMINER